glp-1 agonists for type 2 diabetes receptor and beyond. Part 1: benefits in GLP-1 Receptor Agonists | Incretin
Description
Tirzepatide is the first combination of entero-pancreatic hormones [dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) RA] that has been approved for T2D management based on the findings from the phase 3 SURPASS programme
Kim S, Park DH, Moon S, Gu B, Mantik KEK, Kwak HB, et al
The growth is primarily driven by increasing awareness of diabetes and obesity, coupled with rising healthcare investments
San Martn A, Du P, Dikalova A, Lassgue B, Aleman M, Gngora MC, et al
Cell 165, 16321643
